Barinthus Biotherapeutics
  • Home
  • About Us
    • Overview
    • Our Team
    • A Name with Purpose
  • Approach
    • Overview
    • Tolerance Immunotherapies
  • Technology
    • Overview
    • Viral Vector Platforms
    • SNAP-TI
  • Pipeline
    • Overview
    • Infectious Diseases
    • Autoimmunity
    • Cancer
  • Partnerships
    • Overview
    • Infectious Diseases
    • Autoimmunity
  • Investors
    • Overview
    • News & Filings
    • Events & Presentations
    • Stock Information
    • Corporate Governance
    • Investor FAQs
    • Contact IR
  • Careers
    • Overview
    • Working Here
    • Diversity & Inclusion
    • Our Values
    • Recruitment Companies
  • Contact
    • Overview
    • Patient Enquiries
Select Page

Autoimmunity

See our current Autoimmunity program or contact us (info@barinthusbio.com) for further information about partnership opportunities.

Barinthus Biotherapeutics plc

Unit 6-10
Zeus Building
Rutherford Avenue
Harwell OX11 0DF
United Kingdom

T: +44 (0)1865 818808

Home
About
Sitemap
Privacy Policy
Privacy Notice
Careers
Contact

Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company focused on the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer.

© Barinthus Biotherapeutics 2023 All rights reserved.

  • Follow
  • Follow